MapLight Therapeutics Inc., a biotechnology firm developing treatments for neurological disorders, is seeking to raise $250.8 million in an initial public offering and private placement, proceeding despite the US government shutdown complicating the listing process.
Novo-Backed MapLight Seeks $251 Million in US IPO, Placement
Date:
More like thisRelated
Tampa RV giant Lazydays to delist from Nasdaq
Tampa-based Lazydays Holdings Inc., one of Florida’s most recognized...
Granite Geek: New Hampshire might get access to ‘balcony solar’
I had solar panels put on my roof six...
TSX Today: What to Watch for in Stocks on Monday, November 10
Despite firm gold and silver prices, Canadian stocks...
While BNB and DOT Struggle Under Market Pressure, BlockDAG’s Presale Soars Past $435M!
As market-wide fear grips the sector, the Binance Coin...